Cerner (NASDAQ:CERN)‘s stock had its “hold” rating reiterated by investment analysts at Barclays in a research report issued on Wednesday, April 10th, Stock Target Advisor reports. They currently have a $68.00 price target on the stock. Barclays‘s price target would suggest a potential downside of 0.69% from the stock’s previous close.
A number of other analysts also recently commented on the company. Zacks Investment Research downgraded Cerner from a “hold” rating to a “sell” rating in a research report on Wednesday, March 20th. BidaskClub upgraded Cerner from a “sell” rating to a “hold” rating in a research report on Wednesday, February 13th. Morgan Stanley downgraded Cerner from an “equal weight” rating to an “underweight” rating and cut their target price for the stock from $68.00 to $47.00 in a research report on Thursday, February 28th. SunTrust Banks upgraded Cerner from a “hold” rating to a “buy” rating and raised their target price for the stock from $60.00 to $76.00 in a research report on Wednesday, April 10th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $75.00 target price on shares of Cerner in a research report on Tuesday, April 9th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have given a buy rating to the stock. Cerner presently has a consensus rating of “Buy” and an average price target of $68.67.
CERN opened at $68.47 on Wednesday. The company has a market capitalization of $21.71 billion, a price-to-earnings ratio of 30.98, a price-to-earnings-growth ratio of 2.04 and a beta of 1.03. The company has a current ratio of 2.58, a quick ratio of 2.55 and a debt-to-equity ratio of 0.09. Cerner has a 12-month low of $48.78 and a 12-month high of $69.34.
In other Cerner news, Director John J. Greisch bought 9,000 shares of Cerner stock in a transaction on Thursday, May 2nd. The shares were purchased at an average cost of $67.57 per share, for a total transaction of $608,130.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director R Halsey Wise purchased 7,600 shares of the business’s stock in a transaction dated Tuesday, April 30th. The stock was purchased at an average price of $65.76 per share, for a total transaction of $499,776.00. The disclosure for this purchase can be found here. 4.71% of the stock is owned by insiders.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Essex Savings Bank acquired a new position in Cerner during the fourth quarter worth approximately $27,000. Moody National Bank Trust Division grew its position in Cerner by 72.5% during the first quarter. Moody National Bank Trust Division now owns 483 shares of the company’s stock worth $28,000 after buying an additional 203 shares in the last quarter. JNBA Financial Advisors acquired a new stake in Cerner during the fourth quarter worth approximately $34,000. Creative Financial Designs Inc. ADV grew its position in Cerner by 303.4% during the first quarter. Creative Financial Designs Inc. ADV now owns 710 shares of the company’s stock worth $41,000 after buying an additional 534 shares in the last quarter. Finally, Financial Gravity Companies Inc. acquired a new stake in Cerner during the fourth quarter worth approximately $44,000. 80.90% of the stock is currently owned by hedge funds and other institutional investors.
Cerner Company Profile
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Read More: Depreciation
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.